NEPH — Nephros, Inc.

Nephros, Inc. Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $4.8 million, a 35% increase year-over-year (YoY), marking the second highest quarter in company history.
• Profitability: Achieved net income of $337,000, up from $183,000 in Q3 2024; this is the fifth consecutive quarter of profitability.
• Adjusted EBITDA: Positive $418,000, compared to $295,000 in Q3 2024.
• Gross Margin: Maintained at 61%, consistent with Q3 2024, despite increased inventory handling expenses.
• Active Customer Sites: Over 1,650 as of September 30, 2025.
• Cash Position: Cash balance increased to $5.2 million from $3.8 million at the end of 2024; the company remains debt-free.

2. Strategic Updates and Business Highlights

• Programmatic Business Growth: Recorded the highest level of programmatic business in company history, driven by a robust filtration installation program that enhances customer loyalty and reorder rates.
• PFAS Removal Solution: Recently launched and already in the field, this product is expected to open new markets beyond traditional patient care, including municipalities and labs.
• Sales Strategy: Emphasis on cross-functional coordination and expanding into new verticals, such as dental and government facilities, while maintaining operational discipline.
• Innovation Pipeline: Focus on addressing emerging challenges like microplastics and nanoplastics, with ongoing development to meet regulatory demands.

3. Forward Guidance and Outlook

• Growth Expectations: Management expressed optimism about sustaining growth through strong customer retention, an expanding active site base, and ongoing innovations.
• Market Expansion: Plans to deepen penetration into non-healthcare markets and leverage the PFAS solution to attract new customers.
• Financial Discipline: Commitment to maintaining profitability while strategically investing in growth opportunities.

4. Bad News, Challenges, or Points of Concern

• Tariffs Impact: Increased inventory handling expenses due to tariffs are a concern, although management believes they can manage this impact effectively.
• Regulatory Environment: The evolving regulatory landscape, particularly regarding PFAS and Legionella, presents both opportunities and challenges that require ongoing adaptation.
• Market Competition: The introduction of new products may face competition from established players, necessitating a strong value proposition to retain and attract customers.

5. Notable Q&A Insights

• PFAS Solution: Management highlighted the PFAS removal solution as a significant growth opportunity, particularly in new customer segments that were previously not engaged.
• Sales Strategy: The company is focusing on educating customers about water safety management, which has proven effective in driving sales and customer loyalty.
• Service Revenue: Clarified that service revenue includes both initial installations and regular filter replacements, contributing to the overall growth of the programmatic business.
• SG&A Management: There is a balance between maximizing margins and investing in SG&A to support growth; management is cautious about adding resources but recognizes the need for strategic investments.

This summary encapsulates Nephros' strong performance in Q3 2025, strategic initiatives for future growth, and the challenges that lie ahead as they navigate a competitive and regulatory landscape.